EPOCH-R

EPOCH-R is a chemotherapy regimen used for the treatment of non-Hodgkin lymphoma. It is a combination of several drugs, including etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab.

Overview[edit | edit source]

EPOCH-R is a multi-drug chemotherapy regimen that is used in the treatment of certain types of non-Hodgkin lymphoma. The regimen includes the drugs etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab. These drugs work together to kill cancer cells and prevent them from growing and dividing.

Components[edit | edit source]

Etoposide - This drug works by preventing cancer cells from repairing their DNA, which leads to cell death.
Prednisone - Prednisone is a steroid that helps reduce inflammation and suppress the immune system.
Vincristine - Vincristine works by stopping cancer cells from dividing and growing.
Cyclophosphamide - This drug is a type of chemotherapy that works by damaging the DNA of cancer cells.
Doxorubicin - Doxorubicin works by damaging the DNA of cancer cells and preventing them from dividing and growing.
Rituximab - Rituximab is a type of immunotherapy that works by targeting and killing specific cells in the immune system.

Side Effects[edit | edit source]

Like all chemotherapy regimens, EPOCH-R can cause side effects. These can include nausea, vomiting, hair loss, fatigue, and infection. It is important for patients to discuss these potential side effects with their healthcare provider before starting treatment.

See Also[edit | edit source]

EPOCH-R Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.